CIK 0001211583
- Non-accelerated filer
- Smaller reporting company
FENNEC PHARMACEUTICALS INC.
Sign in to watch- Ticker
- FENC
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- British Columbia, Canada
- Entity type
- Operating
- Phone
- +1 919-636-4530
- Business address
- PO BOX 13628, 68 TW ALEXANDER DRIVE, RESEARCH TRIANGLE PARK, NC, 27709
- Former names
- ADHEREX TECHNOLOGIES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,550,718
- in 5 filings, $1.4M under 10b5-1 plans
Net −$1,550,718. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 7 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-02-28 | MANCHESTER MANAGEMENT PR, LLC 10% owner | Sale | −26,000 | $9.26 | $241K | 166,666 |
| 2018-02-28 | MANCHESTER MANAGEMENT PR, LLC 10% owner | Sale | −17,100 | $9.41 | $161K | 2,183,397 |
| 2017-04-12 | MANCHESTER MANAGEMENT PR, LLC 10% owner | Sale | −200 | $3.45 | $690 | 2,176,882 |
| 2017-04-12 | MANCHESTER MANAGEMENT PR, LLC 10% owner | Sale | −200 | $3.45 | $690 | 1,650,999 |
| 2010-06-08 | Southpoint Capital Advisors LP 10% owner | Sale | −41,504,000 | 200,000,000 |
Page 7 of 7 · 125 trades